课题基金 / 基金详情

PFI:AIR - TT: Microfluidic dose response analyzer for cell-based assays

PFI:AIR - TT: Microfluidic dose response analyzer for cell-based assays
PFI:AIR - TT:用于细胞检测的微流体剂量反应分析仪
批准号:
1445070
负责人:
Siva Vanapalli
金额:
$20.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-15 至 2017-12-31

项目摘要

项目成果

Siva Vanapalli的其他基金

相似基金

相关文献

中文摘要
翻译
该PFI:AIR技术翻译项目专注于翻译一项发现,该发现涉及将数百个纳升级液滴存储在微流体设备中,该设备具有前所未有的控制单个液滴化学成分的能力。这种微流控剂量响应分析仪将通过改变制药行业进行临床前药物发现的方式来提供显着的社会效益。它将在药物发现过程的早期指导决策,帮助减少药物开发周期时间和成本。该项目将产生一个具有定义的设计标准和性能参数的原型,以及基于细胞的测定的验证数据。该技术使用的样品和试剂体积显著减少,消除了移液错误,并允许自动化试剂输送和清洗。与目前占据市场空间的多孔板和移液系统相比,这些功能将带来显著的成本节约、高分辨率数据和更简单的工作流程。该项目解决了从研究发现向商业应用转化的技术障碍。目前的微流体液滴方法缺乏将细胞储存在基底上的精确坐标处,然后添加或去除培养基或药物的能力。因此,这些方法难以培养细胞和筛选药物功效,同时保留纳升试剂体积的益处。在这个项目中,这个瓶颈将通过在一个独特设计的微流体网络中合并存储和移动液滴来解决。通过优化装置设计、细胞密度和流动条件,将产生工作原型和验证数据。此外,参与该项目的人员(研究生和本科生)将接受创新和创业培训。PI和co-PI参与了大学加速器计划,该计划将为参与该项目的学生提供一个了解创业的自然渠道。
英文摘要
This PFI: AIR Technology Translation project focuses on translating a discovery, which involves storing hundreds of nanoliter-scale droplets in a microfluidic device with unprecedented capabilities to control the chemical composition of individual drops. This microfluidic dose response analyzer will deliver significant societal benefit by transforming the way preclinical drug discovery is conducted in the pharmaceutical industry. It will guide decision-making early on in the drug discovery process helping to reduce drug development cycle time and cost. The project will result in a prototype with defined design criteria and performance parameters, as well as validation data on cell-based assays. This technology uses significantly less sample and reagent volumes, eliminates pipetting errors and allows automated reagent delivery and washing. These features will lead to significant cost savings, high-resolution data and simpler workflows compared to multiwell plates and pipetting systems that occupy the current market space.This project addresses the technical obstacles as it translates from research discovery toward commercial application. Current microfluidic drop methods lack the ability to store cells at precise coordinates on a substrate, followed by addition or removal of media or drugs. As a result, such approaches have difficulty culturing cells and screening for drug efficacy, while retaining the benefits of nanoliter reagent volumes. In this project, this bottleneck will be resolved by coalescing stored and moving drops in a uniquely designed microfluidic network. A working prototype and validation data will be produced by optimizing device design, cell density and flow conditions. In addition, personnel involved in this project (graduate and undergraduate students) will receive training in innovation and entrepreneurship. The PI and co-PI have been involved in the University Accelerator Program which will form a natural channel for students working on this project to learn about entrepreneurship.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I-Corps: A microfluidic technology for drug testing on small nematodes
  • 批准号:
    1849943
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2018
  • 负责人:
    Siva Vanapalli
  • 依托单位:
I-Corps: Development and Commercial Feasibility of a Microfluidic Drug Discovery Kit
  • 批准号:
    1355920
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2013
  • 负责人:
    Siva Vanapalli
  • 依托单位:
CAREER:Collective hydrodynamics of confined drops in microfluidic parking networks
  • 批准号:
    1150836
  • 项目类别:
    Standard Grant
  • 资助金额:
    $40.0万
  • 财政年份:
    2012
  • 负责人:
    Siva Vanapalli
  • 依托单位:
Microfluidics to probe partial coalescence in emulsions containing interfacial crystals
  • 批准号:
    0967172
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $27.0万
  • 财政年份:
    2010
  • 负责人:
    Siva Vanapalli
  • 依托单位:
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
  • 批准号:
    51976048
  • 项目类别:
    面上项目
  • 资助金额:
    61.0万元
  • 批准年份:
    2019
  • 负责人:
    邱朋华
  • 依托单位: